| Prevalence and determinants of undernutrition among under-five children residing in urban slums and rural area, Maharashtra, India: a community-based cross-sectional study S Murarkar, J Gothankar, P Doke, P Pore, S Lalwani, G Dhumale, ... BMC public health 20, 1-9, 2020 | 125 | 2020 |
| Reported incidence and risk factors of childhood pneumonia in India: a community-based cross-sectional study J Gothankar, P Doke, G Dhumale, P Pore, S Lalwani, S Quraishi, ... BMC public health 18, 1-11, 2018 | 76 | 2018 |
| Elevated levels of neutrophil activated proteins, alpha-defensins (DEFA1), calprotectin (S100A8/A9) and myeloperoxidase (MPO) are associated with disease severity in COVID-19 … S Shrivastava, S Chelluboina, P Jedge, P Doke, S Palkar, AC Mishra, ... Frontiers in Cellular and Infection Microbiology 11, 751232, 2021 | 39 | 2021 |
| Prevalence of the acute respiratory infections and associated factors in the rural areas and urban slum areas of western Maharashtra, India: a community-based cross-sectional study S Murarkar, J Gothankar, P Doke, G Dhumale, PD Pore, S Lalwani, ... Frontiers in public health 9, 723807, 2021 | 36 | 2021 |
| Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+ Hib) vaccine in comparison with a foreign competitor following primary and … HJ Sharma, S Yadav, SK Lalwani, SV Kapre, SS Jadhav, A Chakravarty, ... Human vaccines 7 (4), 451-457, 2011 | 35 | 2011 |
| Antibody (IgA, IgG, and IgG subtype) responses to SARS-CoV-2 in severe and nonsevere COVID-19 patients HP Patil, PS Rane, S Shrivastava, S Palkar, S Lalwani, AC Mishra, ... Viral Immunology 34 (3), 201-209, 2021 | 31 | 2021 |
| A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw–HBV–Hib, a liquid pentavalent vaccine in Indian infants H Sharma, S Yadav, S Lalwani, V Gupta, S Kapre, S Jadhav, ... Vaccine 29 (13), 2359-2364, 2011 | 26 | 2011 |
| Antibody persistence of two pentavalent DTwP–HB–Hib vaccines to the age of 15–18 months, and response to the booster dose of quadrivalent DTwP–Hib vaccine H Sharma, S Yadav, S Lalwani, S Kapre, S Jadhav, S Parekh, S Palkar, ... Vaccine 31 (3), 444-447, 2013 | 23 | 2013 |
| Safety and immunogenicity of an investigational meningococcal ACWY conjugate vaccine (MenACWY-CRM) in healthy Indian subjects aged 2 to 75 years S Lalwani, S Agarkhedkar, N Gogtay, S Palkar, S Agarkhedkar, U Thatte, ... International Journal of Infectious Diseases 38, 36-42, 2015 | 22 | 2015 |
| Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in India: A randomized, parallel group, non-inferiority trial A Bavdekar, J Oswal, PV Ramanan, C Aundhkar, P Venugopal, D Kapse, ... Vaccine 36 (9), 1220-1226, 2018 | 21 | 2018 |
| Effectiveness of an Indian-made Attenuated influenza A(H1N1)pdm 2009 vaccine: A case control study PS Kulkarni, S Agarkhedkar, S Lalwani, AR Bavdekar, S Jog, SK Raut, ... Human vaccines & immunotherapeutics 10 (3), 566-571, 2014 | 21 | 2014 |
| Clinical study of safety and immunogenicity of pentavalent DTP-HB-Hib vaccine administered by disposable-syringe jet injector in India A Bavdekar, N Malshe, L Ravichandran, A Sapru, A Kawade, S Lalwani, ... Contemporary clinical trials communications 14, 100321, 2019 | 18 | 2019 |
| Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL-Liquid) in Indian infants A Kawade, S Babji, V Kamath, A Raut, CM Kumar, R Kundu, ... Vaccine 37 (19), 2554-2560, 2019 | 18 | 2019 |
| Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA R Kulkarni, HP Patil, S Palkar, S Lalwani, AC Mishra, V Arankalle Journal of Virological Methods 287, 113996, 2021 | 17 | 2021 |
| Meager perception of preconception care among women desiring pregnancy in rural areas: a qualitative study using focus group discussions PP Doke, JS Gothankar, PD Pore, SH Palkar, AP Chutke, AV Patil, ... Frontiers in Public Health 9, 689820, 2021 | 16 | 2021 |
| A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent … N Rathi, S Desai, A Kawade, P Venkatramanan, R Kundu, SK Lalwani, ... Vaccine 36 (52), 7943-7949, 2018 | 16 | 2018 |
| Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine S Desai, N Rathi, A Kawade, P Venkatramanan, R Kundu, SK Lalwani, ... Vaccine 36 (37), 5519-5523, 2018 | 16 | 2018 |
| Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small … HJ Sharma, VD Patil, SK Lalwani, MV Manglani, L Ravichandran, ... Vaccine 30 (3), 510-516, 2012 | 16 | 2012 |
| Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital V Arankalle, A Kulkarni-Munje, R Kulkarni, S Palkar, R Patil, J Oswal, ... Frontiers in Immunology 13, 928501, 2022 | 15 | 2022 |
| Early and high SARS-CoV-2 neutralizing antibodies are associated with severity in COVID-19 patients from India S Shrivastava, S Palkar, J Shah, P Rane, S Lalwani, AC Mishra, ... The American Journal of Tropical Medicine and Hygiene 105 (2), 401, 2021 | 15 | 2021 |
Sanjay LalwaniProfessor, Department of Pediatircs, Bharati Vidyapeeth (DTU) Medical College, Pune在 bharatividyapeeth.edu 的电子邮件经过验证
